SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX is drawing attention after reaching a 52-week high ahead of an expected Q3 report, with traders watching BRIUMVI sales and whether results support the rally. Buyout speculation and possible short covering are also prominent, but the acquisition talk is unconfirmed and some traders attribute the strength to the companys operating momentum instead.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazons quarterly results and heavy AI infrastructure spending drove debate, as investors weighed weaker-than-expected results and sharply negative free cash flow against accelerating AWS growth and its outlook. Traders were split between concerns that cash burn and rising investment could pressure the stock and dip-buyers who viewed the initial selloff as overdone; shares rebounded substantially from their lows.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Better-than-expected quarterly results and strength in parks and streaming have renewed optimism, with traders pointing to analyst upgrades and a potential technical breakout. Others remain skeptical, citing Disneys long-running share-price stagnation and resistance levels.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intels steep drop followed weak forward guidance despite a solid quarter, with traders focused on softer PC demand, manufacturing constraints and analyst downgrades; the pressure also fed into a broader semiconductor and tech selloff. The community is split between calling the reaction excessive and buying the dip, and warning that the outlook and execution problems could prolong the decline.

United States Natural Gas Fund LP. - United States Natural Gas Fund

United States Natural Gas Fund, LP

UNG is drawing attention as natural gas prices slide amid mild-weather forecasts that point to weaker heating demand, with surplus inventories adding pressure. Traders are split between buying the decline ahead of winter and expecting further weakness if warm conditions persist; colder forecasts or storage data are seen as potential catalysts for a shift.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit is drawing attention ahead of the November 14 FDA decision on ivonescimab plus chemotherapy for EGFR-mutated lung cancer, with traders weighing the Phase 3 results and recent positive biliary-cancer data against regulatory concerns, including the lack of statistically significant overall-survival results. Bulls see approval potential and broader promise for the drug, while skeptics stress that the decision remains uncertain and could hinge on FDA concerns about the trial population or manufacturing.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on the upcoming FDA decision on Capricors deramiocel for Duchenne muscular dystrophy, with traders focusing on the amended upper-limb-function data and recent rare-disease discussions. New commercial-launch job postings and other FDA approvals have fueled optimism about a favorable decision, while skeptics caution that neither hiring nor regulatory flexibility guarantees approval and debate the risk of a CRL; some also attribute price swings to short covering or rumors of a leak.

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Agenus Inc

Agenuss BOT+BAL combination drew attention after Phase 2 NEOASIS data at ESMO showed strong pathologic responses in a small dMMR colon cancer cohort, alongside discussion of sarcoma results. Traders called the findings encouraging but debated their significance given the small, early-stage studies and awaited Phase 3 confirmation, while some questioned why the share price weakened despite the data and raised dilution and execution concerns.

Hedera (HBAR) is a cryptocurrency launched in 2017. Hedera has a current supply of 50,000,000,000 with 44,327,155,828.93500734 in circulation. The last known price of Hedera is 0.07221819 USD and is up 4.74 over the last 24 hours. It is currently trading on 465 active market(s) with $92,347,671.42 traded over the last 24 hours. More information can be found at https://www.hedera.com/.

Hedera Hashgraph

HBARs sharp rally and elevated volume are being linked by traders to IBM-related cloud news and Hederas reported connections to NVIDIAs AI safety platform. Enthusiasm over enterprise and AI use cases is tempered by profit-taking and skepticism that the announcements will translate into meaningful adoption or token demand.

Cameco Corp. engages in the provision of uranium. It operates through the following segments: Uranium and Fuel Services. The Uranium segment is involved in the exploration for, mining, milling, purchase, and sale of uranium concentrate. The Fuel Services segment deals with the refining, conversion, and fabrication of uranium concentrate and the purchase and sale of conversion services. The company was founded in 1988 and is headquartered in Saskatoon, Canada.

Cameco Corp.

Camecos Q3 report and narrower 2026 production guidance are driving the selloff, with traders focusing on weaker results and production setbacks, including at Cigar Lake. Some see the report as disappointing and the stock as overvalued, while long-term bulls point to firm uranium prices and nuclear demand.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HSY Q3 Earnings Call Highlights 2027 Growth and Margin Risks

Hershey maintains its 2027 sales growth outlook of 2-4%, banking on innovation and productivity gains as weak consumer demand and rising costs threaten margins.

Why Hershey (HSY) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

HSY Q3 Earnings Top Estimates on Cost Relief and Pricing Gains

Hershey's Q3 earnings surge 103.1% as pricing gains, cost relief and tariff refunds boost margins, prompting a higher 2026 outlook despite volume pressures.


Here's What Key Metrics Tell Us About Hershey (HSY) Q3 Earnings

While the top- and bottom-line numbers for Hershey (HSY) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Hershey (HSY) Beats Q3 Earnings and Revenue Estimates

Hershey (HSY) delivered earnings and revenue surprises of +24.53% and +0.65%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Hershey Declares Quarterly Dividends

Hershey Declares Quarterly Dividends Hershey Declares Quarterly DividendsPR NewswireHERSHEY, Pa., Oct. 29, 2026 HERSHEY, Pa., Oct. 29, 2026 /PRNewswire/ -- The Board of Directors of The Hershey Company (NYSE: HSY) today announced quarterly dividends of $1.452 on the Common Stock and $1.320 on the...

Hershey Reports Third-Quarter 2026 Financial Results

Hershey Reports Third-Quarter 2026 Financial Results Hershey Reports Third-Quarter 2026 Financial ResultsPR NewswireHERSHEY, Pa., Oct. 29, 2026 HERSHEY, Pa., Oct. 29, 2026 /PRNewswire/ -- The Hershey Company (NYSE: HSY) today announced net sales and earnings for the third quarter ended September27...

Sysco Q1 Earnings on the Horizon: Essential Insights for Investors

SYY's fiscal first-quarter results are likely to reflect sales and earnings growth, supported by foodservice strength, brand expansion and operational efficiencies.

CHD Q3 Earnings on the Horizon: Essential Insights for Investors

CHD's third-quarter earnings face pressure from portfolio changes, rising costs and higher expenses, while innovation and organic sales growth offer support.

Insights Into Hershey (HSY) Q3: Wall Street Projections for Key Metrics

Beyond analysts' top-and-bottom-line estimates for Hershey (HSY), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2026.

$HSY Q3 &#39;26 Earnings Results &amp; Recap

Hershey updated 2026 full-year outlook to net sales growth of approximately 5%, organic net sales growth of approximately 3%, reported EPS growth of 84% to 90%, and adjusted EPS growth of 36% to 38.5%.

Stocktwits

Hershey Company

 Q3 '26 Earnings Results & Recap

Hershey updated 2026 full-year outlook to net sales growth of approximately 5%, organic net sales growth of approximately 3%, reported EPS growth of 84% to 90%, and adjusted EPS growth of 36% to 38.5%.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Hershey updated 2026 full-year outlook to net sales growth of approximately 5%, organic net sales growth of approximately 3%, reported EPS growth of 84% to 90%, and adjusted EPS growth of 36% to 38.5%.

Hershey's Q3 organic sales increased 0.8% amid approximately 10 points of volume decline; North America Salty Snacks income decreased, and International sales and volume declined amid price elasticity and shipment timing.

Hershey gained U.S. salty-snack market share as takeaway increased 4.0%; North America Confectionery segment income and margin increased, and Hershey expects approximately $100M in Advancing Agility & Automation Initiative savings.

The Hershey Co. engages in the manufacture and marketing of chocolate, sweets, mints and confectionery products. The firm operates through the following segments: North America Confectionery, North America Salty Snacks and International. The North America Confectionery segment is responsible for the traditional chocolate and non-chocolate confectionery market position of the company, as well as its grocery and snacks market positions, in the United States and Canada. The North America Salty Snacks segment is responsible for the salty snack products in the United States. The International segment includes the combination of all other operating segments, including those geographic regions where the company operates outside of North America. Its brands include Hershey's, Reese's, and Kisses. The company was founded by Milton S. Hershey in 1894 and is headquartered in Hershey, PA.

KHC, CLX, HSY Stocks In Focus: Consumer Staples Lag The Market, But Analyst Sees Potential In These Three Names 

Equity

Bullish Sentiment

<ul class="summary-bullets"><li>Morningstar said alcoholic beverages and packaged goods appear undervalued as consumers seek cheaper options.&nbsp;</li><li>Kraft Heinz trades 40% below Morningstar’s $41 fair value estimate.&nbsp;</li><li>Clorox trades 45% below Morningstar’s $154 fair value estimate, with key brands gaining market share.&nbsp;</li></ul><p>Consumer defensive stocks lagged the broader market in the third quarter, but Morningstar sees value in the sector as valuations remain attractive. Kraft Heinz (KHC), Clorox Co. (CLX) and Hershey Co. (HSY) stand out as top picks, trading at discounts of 40%, 45% and 30%, respectively, to Morningstar’s fair value estimates.&nbsp;</p><h2 class="st-heading-2">Alcohol And Packaged Goods Lead On Valuation</h2><p>Erin Lash, director of consumer equity research at Morningstar, said food, beverage, and household product stocks could rise as companies adjust to consumers spending less.&nbsp;</p><figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20261011_105234323_6080b4a8cc.png" alt="koyfin_20261011_105234323.png" width="2400" height="1240"></figure><p>Lash said alcoholic beverage producers trade at an average 24% discount to Morningstar's fair value estimates, while consumer packaged goods companies sit at a 20% discount. The broader consumer defensive group also appears undervalued, with the median stock trading approximately 5% below its estimated worth.</p><h2 class="st-heading-2">Higher Transportation Costs Complicate Pricing</h2><p>Higher trucking and warehousing costs are squeezing company profits, while U.S. food prices have risen 33% since 2019, said Lash. As shoppers become more price-conscious and switch to cheaper options, companies face pressure to control costs and justify further price increases.&nbsp;</p><p>Higher prices have hurt sales volumes for packaged goods companies. Quarterly organic sales volumes have fallen by an average of 0.2% since early 2023, compared with nearly 2% growth from 2018 to late 2021. Morningstar says the decline may be slowing as companies offer products that customers want.&nbsp;</p><h2 class="st-heading-2">Kraft Heinz Trades At 40% Discount: Morningstar&nbsp;</h2><p>Kraft Heinz trades at a 40% discount to Morningstar's $41 fair value estimate and offers a dividend yield close to 7%. The company dropped its planned separation earlier this year and committed another $700 million to brand development. Morningstar views the decision positively, noting that about 70% of the company's sauces portfolio is gaining market share.</p><p>RBC Capital started coverage of Kraft Heinz last month with an ‘Outperform’ rating and a $32 price target, implying a 435 upside to the stock’s close on Friday. The analyst said the company is making major changes that are expected to show their full impact in 2027 and expects Kraft Heinz’s organic revenue and earnings to exceed analysts’ average estimates in 2027.&nbsp;</p><p><a href="https://stocktwits.com/symbol/KHC">Kraft Heinz stock</a> edged 0.04% higher overnight, ahead of Monday. The stock slumped 10% in September, recording its worst month in four years.&nbsp;</p><h2 class="st-heading-2">Morningstar Sees Upside For Clorox, Hershey&nbsp;</h2><p>Clorox trades 45% below Morningstar’s $154 fair value estimate. The company has gained market share in Hidden Valley Ranch and Glad trash bags, which together generate about one-fifth of its sales. Lash expects efficiency improvements to help support continued brand investment despite recent operating challenges.</p><p>However, on Oct.1, TD Cowen cut its price target on the household products maker to $85 from $90 and maintained a ‘Hold’ rating. The firm lowered its FY27 earnings forecast to $5.55 per share, below Clorox’s earlier estimate of $5.70 to $6.00, citing higher shipping and oil costs and continued weakness in several business areas.&nbsp;<a href="https://stocktwits.com/symbol/CLX">Clorox stock</a> inched 0.2% lower overnight, heading into Monday.&nbsp;</p><p>Hershey trades at a 30% discount to Lash’s $230 fair value estimate. Morningstar believes product innovation and marketing can help the chocolate maker defend its market position despite softer discretionary spending and consumer interest in healthier foods.</p><p>On Friday, BofA provided heft to Morningstar’s argument saying that though concerns about consumer staples remain ahead of third-quarter earnings, buying trends are starting to stabilize and investor sentiment has improved slightly from the previous quarter.&nbsp;</p><p><a href="https://stocktwits.com/symbol/HSY">Hershey stock</a> edged up 0.2% overnight after a 3.7% decline last week.&nbsp;</p><p>So far this year, KHC, CLX, and HSY stocks have declined 8% to 16%.&nbsp;</p><p>Also see:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-did-mrna-hum-lite-stocks-surge-to-52-week-highs-last-week/cZx4wjZRBFQ">Why Did MRNA, HUM, LITE Stocks Surge To 52-Week Highs Last Week?</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

 In this photo illustration, a bottle of Heinz tomato ketchup is displayed next to a box of Kraft Mac & Cheese.

Consumer defensive stocks lagged the broader market in the third quarter, but Morningstar sees value in the sector as valuations remain attractive. Kraft Heinz (KHC), Clorox Co. (CLX) and Hershey Co. (HSY) stand out as top picks, trading at discounts of 4

KHC, CLX, HSY Stocks In Focus: Consumer Staples Lag The Market, But Analyst Sees Potential In These Three Names

Morningstar sees room for food, beverage and household product stocks to rise as companies adjust to consumers spending less. 


Clorox Co.

Kraft Heinz Co

Consumer Staples Select Sector SPDR Fund

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$165.61
Prev Close	$160.28
Open	$162.21
Dividend Yield	3.01%
50-Day Moving Average	$169.69
Beta	0.03
Avg. Volume	1.48M
PE Ratio	21.36

52-Week High	$239.48
52-Week Low	$156.16
Market Capitalization	$33.28B
EPS (Annual)	$4.34
Price to Book	6.83
Revenue Per Employee	$596,712.22

Feed

News

Sentiment

Earnings

Fundamentals

Info

HSY Fundamentals